MUSSALLEM MICHAEL A 4
4 · Edwards Lifesciences Corp · Filed Apr 4, 2024
Insider Transaction Report
Form 4
MUSSALLEM MICHAEL A
DirectorChairman & CEO
Transactions
- Exercise/Conversion
Common Stock
2024-04-04$36.75/sh+29,350$1,078,613→ 33,835.82 total - Sale
Common Stock
2024-04-04$93.72/sh−2,712$254,169→ 30,923.82 total - Sale
Common Stock
2024-04-04$92.70/sh−16,618$1,540,489→ 4,485.82 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2024-04-04−29,350→ 29,350 totalExercise: $36.75From: 2017-06-11Exp: 2024-05-10→ Common Stock (29,350 underlying) - Sale
Common Stock
2024-04-04$94.19/sh−200$18,838→ 33,635.82 total - Sale
Common Stock
2024-04-04$91.54/sh−9,820$898,923→ 21,103.82 total
Holdings
- 4,038,377(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023.
- [F2]This transaction was executed in multiple trades at prices ranging from $94.185 to $94.200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $93.130 to $94.130. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $91.120 to $92.100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $92.125 to $93.120. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.